Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Priced IPO
Solaredge Technologies, Inc. (SEDG)
The Marygold Companies (MGLD)
Blue Water Vaccines (BWV)
Meihua International Medical Technologies (MHUA)
Smart for Life (SMFL)
Vivakor (VIVK)
TC BioPharm Holdings (TCBP)
Direct Digital Holdings, Llc (DRCT)
Modiv (MDV)
Sky Technologies (SKYX)
Modular Medical (MODD)
HeartCore Enterprises (HTCR)
Arcellx, Inc. (ACLX)
Silver Spike Investment Corp. (SSIC)
Maris-Tech Ltd. (MTEK)
Yoshitsu Co., Ltd. (TKLF)
Tpg Inc. (TPG)
Hillstream BioPharma (HILS)
Hour Loop (HOUR)
Vigil Neuroscience, Inc. (VIGL)
More companies

Lux Health Tech Acquisition (LUXAU)

Sector - SPAC

Price chart

-100%
Return from IPO

Last SPACs News

IPO Profile

About company

They are a newly incorporated blank check company. They intend to capitalize on the ability of their management team to identify, acquire and operate a business at the intersection of the healthcare and technology industries. Their management team and board of directors will be led by Peter Hébert, their Chairman. Josh DeFonzo will serve as their Chief Executive Officer, and a member of their board of directors. Segolene Scarborough will serve as their Chief Financial Officer and Treasurer. They expect Dr. Bijan Salehizadeh, Senator Joseph Robert "Bob" Kerrey and Dr. Fred Moll to join their board of directors at the closing of this offering. Mr. Peter Hébert is a co-founder and managing partner of Lux and oversees Lux’s investments at the intersection of technology and medical devices, including Auris Health, which was acquired by Johnson & Johnson, and Avail Medsystems. Mr. Josh DeFonzo is a former President at Johnson & Johnson (Robotics & Digital Solutions), the former Chief Operating Officer of Auris Health, and a former Chief Commercial Officer of CareDx (Nasdaq: CDNA).
Industry
Blank Checks
CEO CFO
-
Employees Founded
3 2020

Contacts

Address: 920 Broadway, 11th Floor New York, Ny 10010, Us

Telephone: (646) 475-4385

Web page: http://luxcapital.com

IPO information

First Trade Date 10/27/2020
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 30
Shares Revised (MM) 30
Expected offer amount (MM) $300
Realized offer amount(MM) $300

Financial Data (last reporting year)

Market Cap (MM) $375
Revenues (MM) $0
Net Income (Loss) (MM) $0

Voting

What do you think will happen with the LUXAU share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Underwriters
Credit Suisse
CO-Managers
Stifel